Iranian scientists have started developing a vaccine for protecting women from cervical cancer, taking a giant step in preventing the deadly disease.
Iranian Deputy Health Minister for Research and Technology Mostafa Ghanei said Iranian Health Ministry and Pasteur Institute have begun development of a vaccine for cervical cancer, noting the efficiency of the vaccine as a cure for cancer has been verified.
Ghanei pointed out the vaccine which plays an effective role in women's health would be produced by the next three years.
Cervical cancer is the term for a malignant neoplasm arising from cells originating in the cervix uteri. One of the most common symptoms of cervical cancer is abnormal bleeding, but in some cases there may be no obvious symptoms until the cancer has progressed to an advanced stage. Treatment usually consists of surgery in early stages, and chemotherapy or radiotherapy in more advanced stages of the disease.
Worldwide, cervical cancer is the fifth most deadly cancer in women. It affects about 16 per 100,000 women per year and kills about 9 per 100,000 per year.
Ghanei also noted rabies vaccine, flu and Haemophilus vaccines would be produced locally by the next two years, pointing out that Iran has not been included in the World Trade Organization(WTO) list of members due to western countries' hostilities, therefore it would be an opportunity for the country to produce all biotechnological medicines inside the country.
He continued, "Iran would be the biggest producer of biosimilars or follow-on biologics by the next two years."
He stressed Iran is ranked first in the region in producing biotechnological medicines and stands fifth in Asia.
... Payvand News - 03/25/16 ... --